Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma
Clinical trial NCT01472562 · COMPLETED
Trial details
- NCT number
- NCT01472562
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-29
- Primary completion
- 2014-04-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.